The Patent Finder
UC

Universite Claude Bernard Lyon 1

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

174 patents currently held

34 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.

The next term ends in Nov 2028. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Nov 2028
Next term end
155
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Methods and Products for Genetic Engineering US 11,649,264
Cited by 19 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2036. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Ends no later than Oct 2036 · Medium confidence
Also notable
Methods and Pharmaceutical Compositions for the Treatment of Hepatitis B Virus Infection US 9,895,380
Cited by 44 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Ends Nov 2034 · High confidence
Also notable
Antibodies Directed Against ICOS and Uses Thereof US 9,376,493
Cited by 28 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Ends Oct 2032 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Electrophysiological Method for Assessing the Effectiveness of a Hearing Aid (US 10,299,696) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 1 fee due Dec 4, 2026
    The maintenance fee for Novel Silicone Composition Crosslinking Catalysts (US 10,308,770) comes due Dec 4, 2026. Unpaid by Jun 4, 2027, it lapses early.
  • 4 fees due Jan 4 to 28, 2027 · next Jan 4
  • 2 fees due Feb 22 to 28, 2027 · next Feb 22
  • 1 fee due Mar 26, 2027
    The maintenance fee for Biocell with Fuel Reservoir (US 11,769,894) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
  • 8 fees due Apr 1 to 30, 2027 · next Apr 1
  • 3 fees due May 12 to 26, 2027 · next May 12
  • 2 fees due Jun 19, 2027
  • 6 fees due Jul 14 to 30, 2027 · next Jul 14
  • 1 fee due Aug 18, 2027
    The maintenance fee for Sentinel Signal for Adaptive Retention Time in Targeted MS Methods (US 10,566,178) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 4 fees due Oct 2 to 28, 2027 · next Oct 2
  • 2 fees due Nov 3 to 12, 2027 · next Nov 3

Which patents, and when each one lapses · Pro

Recent changes

  • 6 of the patents on this record were granted since Aug 23, 2026
  • 2 terms have ended since Aug 23, 2026

What they patent

The largest of its 155 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,357,545Hybrid Nanoparticles with LN2O3 Core and Carrying Biological Ligands, and Method of Preparation Thereof
In force
 · High confidence
In forceHigh confidence
US 8,357,907Method and Device for Real-Time Measurement of a Local Dose Upon Bombardment of a Target by Hadrons by Means of Prompt Gamma Rays
In force
 · High confidence
In forceHigh confidence
US 8,481,691Method for Selectively Extracting Membrane Proteins Using Calixarenes
In force
 · High confidence
In forceHigh confidence
US 9,170,263Novel Method for Quantifying Proteins by Mass Spectrometry
In force
 · High confidence
In forceHigh confidence
US 9,018,580Method for Detecting Molecules Through Mass Spectrometry
In force
 · High confidence
In forceHigh confidence
US 8,802,425Method for the Hypothermic Perfusion of a Cardiac Organ, and Device for the Implementation Thereof
In force
 · High confidence
In forceHigh confidence
US 9,023,814Glycomimetic Compounds as Anti-Infectious Against Pathogens Lectins
In force
 · High confidence
In forceHigh confidence
US 8,778,341ANTI-CK8 Antibodies to Be Used for Treating Colorectal Cancers and Identifying Metastatic And/Or Invasive Phenotypes
In force
 · High confidence
In forceHigh confidence
US 9,434,800Method of Embolization using a Radiopaque, Non-Biodegradable, Water-Insoluble Iodinated Benzyl Ether of PolyI(Vinyl Alcohol)
In force
 · High confidence
In forceHigh confidence
US 8,901,185A Hybrid Organic-Inorganic Material Constituted by a Silica Network Having Photochromic Agents and Optical Power Limiting Agents as a Doping Agent in the Material
In force
 · High confidence
In forceHigh confidence
10 of 174 patents shown.
Pro members see all 174.
Pro members: see all 174 patents
Also on record, not counted in the 174: 34 patents in force now held by others · 85 patents ended · 174 applications pending · 152 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited